TG Therapeutics, Inc. (TGTX) Competitors & Peers
The 5 largest companies in the same industry as TG Therapeutics, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $508.25 | P/E 29.8RSI 43Cap 130.0 B |
| REGN | Peer | $785.42 | P/E 19.4RSI 46Cap 80.6 B |
| ARGX | Peer | $997.41 | P/E 38.0RSI 53Cap 62.1 B |
| RVMD | Peer | $192.86 | RSI 42Cap 42.5 B |
| CSLLY | Peer | $31.73 | P/E 18.2RSI 71Cap 60.1 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- MRKCompetitor
Competes in multiple sclerosis therapeutic spaces.
Model-inferred, unverified — treat as a lead, not evidence - BIIBCompetitor
Competes in multiple sclerosis treatment markets, where Biogen operates Ocrevus.
Model-inferred, unverified — treat as a lead, not evidence